糖化血红蛋白之外持续葡萄糖监测衍生指标对优化个体化血糖控制的重要性
该研究在999例2型糖尿病门诊患者中测定持续葡萄糖监测(CGM)指标(目标范围内时间TIR、低于范围时间TBR、高于范围时间TAR),并按HbA1c分类比较,进一步按年龄、降糖药类型和肾功能分层。结果显示较高HbA1c并不总能防止低血糖,CGM指标可补充HbA1c监测,尤其对老年人、胰岛素和/或磺脲类使用者及慢性肾脏病患者有益。
要点
- HbA1c<53 mmol/mol(<7.0%)时,≥65岁患者夜间TBR显著高于<65岁者。
- HbA1c<53及53-63 mmol/mol时,使用胰岛素和/或磺脲类者TAR、TBR显著更高、TIR更低。
- HbA1c<53、53-63及64-74 mmol/mol时,eGFR<60者部分时段TBR显著更高。
核心结论
- 较高HbA1c水平并不总能防止低血糖发作,使用CGM指标补充HbA1c监测有益,尤其对老年人、胰岛素和/或磺脲类使用者及慢性肾脏病患者。
研究设计与样本
- 在999例2型糖尿病门诊患者中测定CGM指标(TIR、TBR、TAR),按HbA1c分类比较,并在相同HbA1c分类内按年龄、降糖药类型和肾功能分层比较。
主要发现
- HbA1c<53 mmol/mol(<7.0%)分类中,≥65岁患者夜间TBR显著高于<65岁患者。
- HbA1c<53及53-63 mmol/mol(7.0-7.9%)分类中,使用胰岛素和/或磺脲类者TAR和TBR显著更高、TIR显著更低。
- HbA1c 64-74 mmol/mol(8.0-8.9%)分类中,使用胰岛素和/或磺脲类者TBR显著更高。
- HbA1c<53、53-63及64-74 mmol/mol分类中,eGFR<60 mL/min/1.73 m2者部分时段TBR显著高于eGFR≥60者。
关键数值与推荐
- HbA1c分类为<53 mmol/mol(<7.0%)、53-63 mmol/mol(7.0-7.9%)、64-74 mmol/mol(8.0-8.9%)和≥75 mmol/mol(9.0%)。
- CGM指标包括TIR、TBR和TAR。
- 肾功能分层采用eGFR<60 mL/min/1.73 m2与eGFR≥60 mL/min/1.73 m2。
临床怎么用
- 原文结论认为使用CGM指标补充HbA1c监测有益,尤其对老年人、胰岛素和/或磺脲类使用者及慢性肾脏病患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Current guidelines recommend assessing glycemic control using continuous glucose monitoring (CGM) and hemoglobin A1c (HbA1c) measurement. OBJECTIVE: This study aimed to clarify the characteristics of patients who might benefit from CGM metrics in addition to HbA1c monitoring. METHODS: CGM metrics, specifically time in range (TIR), time below range (TBR), and time above range (TAR), were determined in 999 outpatients with type 2 diabetes and compared between HbA1c categories (HbA1c < 53 mmol/mol [7.0%, HbA1c < 53], HbA1c 53-63 mmol/mol [7.0-7.9%, HbA1c 53-63], HbA1c 64-74 mmol/mol [8.0-8.9%, HbA1c 64-74], and HbA1c ≥ 75 mmol/mol [9.0%, HbA1c ≥ 75]) and between patients with identical HbA1c categories who were stratified by age, types of antidiabetic agents, and renal function. RESULTS: For HbA1c < 53 category, patients aged ≥ 65 years had a significantly higher nocturnal TBR than those aged < 65 years. For HbA1c < 53 and HbA1c 53-63 categories, patients receiving insulin and/or sulfonylureas had a significantly higher TAR and TBR, and a lower TIR than those not receiving these drugs, and for HbA1c 64-74 category, they had a significantly higher TBR. For HbA1c < 53, HbA1c 53-63, and HbA1c 64-74 categories, patients with an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2 had a significantly higher TBR during some periods than those with an eGFR ≥ 60. CONCLUSION: Higher HbA1c levels do not always protect against hypoglycemic episodes. Our data demonstrate that using CGM metrics to complement HbA1c monitoring is beneficial, especially in older people, users of insulin and/or sulfonylureas, and patients with chronic kidney disease.
引用
- Yoshii H, Mita T, Katakami N, et al. The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control. J Clin Endocrinol Metab. 2022. PMID: 35908248. doi:10.1210/clinem/dgac459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。